NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/16/2025
Back to search
Official data from USPTO
CURADEL PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
12/17/2025
Trademark type
Combined
Nice classes
35, 42, 44
Filing date
04/24/2025
Registration date
12/16/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/16/2025
Last transaction
12/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/19/2024
First use in commerce
02/19/2024
Drawing code
3
Owner type
03
Owner location
Natick, MA
Examiner
PODESTA,GIDETTE
Law office
N70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of stylized purple wording "CURADEL PHARMA", to the left of which is a shaded green circle surrounded by three purple curved lines extending in opposite directions.
Holders and representatives
Holders
Curadel Surgical Innovations, Inc.
Representatives
Gregory N. Brescia Gordon & Rees LLP
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Providing consumer information in the field of cancer treatment and diagnosis via the Internet and social media
Class 42
Medical and scientific research services in the field of cancer treatment and diagnosis
Class 44
Providing health information in the field of cancer treatment and diagnosis via the Internet and social media
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/16/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/28/2025
PUBO
PUBLISHED FOR OPPOSITION
10/28/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/22/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2025
IUAA
USE AMENDMENT ACCEPTED
09/26/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
09/25/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/25/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
09/25/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/25/2025
DOCK
ASSIGNED TO EXAMINER
09/17/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/16/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
07/18/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/17/2025
ALIE
ASSIGNED TO LIE
07/16/2025
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
07/03/2025
IUAF
USE AMENDMENT FILED
07/03/2025
DRRR
DIVISIONAL REQUEST RECEIVED
07/03/2025
EAAU
TEAS AMENDMENT OF USE RECEIVED
07/03/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
07/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/24/2025
NWAP
NEW APPLICATION ENTERED
04/24/2025
Continuous trademark protection
Get notified about every new filing that threatens CURADEL PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.